Hostname: page-component-848d4c4894-mwx4w Total loading time: 0 Render date: 2024-06-16T21:44:03.543Z Has data issue: false hasContentIssue false
  • English
  • Français

Antibody responses of burned patients immunized with a polyvalent Pseudomonas vaccine

Published online by Cambridge University Press:  15 May 2009

R. J. Jones
R. J. Jones
Affiliation:
MRC Industrial Injuries and Burns Unit, Birmingham Accident Hospital, Bath Row, Birmingham B15 1NA
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In two controlled clinical trials of a polyvalent pseudomonas vaccine, vaccinated burned patients showed higher antibody titres to the 16 antigens in the vaccine and higher titres of a passively transferable protective antibody than was found in unvaccinated burned patients.

Type
Research Article
Information
Journal of Hygiene , Volume 82 , Issue 3 , June 1979 , pp. 453 - 462
Copyright
Copyright © Cambridge University Press 1979

References

REFERENCES

Bergan, T. (1975). Epidemiological typing of Ps. aeruginosa. In Resistance of Pseudomonas aeruginosa (ed. Brown, M. R.), p. 189. London.Google Scholar
Davis, B. D., Lilly, H. A. & Lowbury, E. J. L. (1968). Gram-negative bacilli in burns. Journal of Clinical Pathology 22, 634.CrossRefGoogle Scholar
Jones, R. J. (1974). Topical chemoprophylaxis against infection of burns. Proceedings of the International Symposium on treatment of burns. Beverwyk Netherlands.Google Scholar
Jones, R. J., Hall, M. H. & Ricketts, C. R. (1972). Passive protective properties of serum fractions from mice inoculated with an anti-pseudomonas vaccine. Immunology 23, 889.Google ScholarPubMed
Jones, R. B. & Lowbury, E. J. L. (1963). Staphylococcal antibodies in burned patients. British Journal of Experimental Pathology 44, 576.Google ScholarPubMed
Jones, R. J. & Lowbury, E. J. L. (1972). Early protection by vaccines against pseudomonas aeruginosa colonising burns. British Journal of Experimental Pathology 53, 659.Google ScholarPubMed
Jones, R. J. & Roe, E. A. (1975). Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent pseudomonas vaccine. British Journal of Experimental Pathology 56, 34.Google ScholarPubMed
Jones, R. J., Roe, E. A. & Gupta, J. L. (1978). Low mortality in burned patients vaccinated with a polyvalent pseudomonas vaccine. Lancent ii, 401.CrossRefGoogle Scholar
Jones, R. J., Roe, E. A., Lowbury, E. J. L., Miler, J. J. & Spilsbury, J. F. (1976). A new pseudomonas vaccine: Preliminary trial on human volunteers. Journal of Hygiene 76, 429.CrossRefGoogle ScholarPubMed
Lowbury, E J. L. (1976). Prophylaxis and treatment for infection of burns British Journal of Hospital Medicine 566.Google Scholar
Miler, J. M., Spilsbury, J. F., Jones, R. J., Roe, E. A. & Lowbury, E. J. L. (1977). A new polyvalent pseudomonas vaccine. Journal of Medical Microbiology 10, 19.CrossRefGoogle ScholarPubMed
Roe, E. A. & Jones, R. J. (1978). An index for estimating resistance to infection in patients with burns. Burns 4, 240.CrossRefGoogle Scholar
Wahba, A. H. (1965). Hospital infection with Pseudomonas pyocyanea: An investigation by a combined pyocine and serological typing method. British Medical Journal i, 86.CrossRefGoogle Scholar